Suicidality phenomena, suicidality events, and suicidality disorders are not the same things, should not be confused with each other, and need to be measured separately from each other. The Tampa – Classification Algorithm for Suicidality Assessment (T-CASA) was designed to capture the details about events of suicidality.
Measuring suicidality events with precision is useful in several situations. For example, when doing neuroimaging studies researchers may need to know very specifically which type of suicidality event and its related phenomena that the patient experienced during the functional neuroimaging. We suspect that the neuroimage of a patient having an unexpected suicidal impulse attack will look different from a neuroimage of a patient experiencing a suicidal delusion. Both of these would likely be different from a neuroimage of a patient having suicidality as a later consequence of Major Depressive Disorder (a mood disorder).
A medication that increases the frequency of treatment emergent suicidality events of one type, may improve another type of suicidality event. For example, an antidepressant that effectively reduces suicidality as a later consequence of Major Depressive Disorder in an elderly subject is likely to be associated with an increase in the frequency of up-switches in unexpected suicidal impulse attacks in patients with Impulse Attack Suicidality Disorder. (See chapter 12.2 in Sheehan DV, Giddens JM. (2015). Suicidality: A Roadmap for Assessment and Treatment. (1st ed.). Tampa, FL: Harm Research Press.) Using the T-CASA system, regulatory agencies may be able to detect the worsening of one type of suicidality event in some subjects, while at the same time they see an improvement in another type of suicidality event in other subjects on the same treatment.
This data can be elicited from the patient using the T-CASA Structured Interview and can be documented and tracked over time using the T-CASA Tracking Logs. For compatibility with the Sheehan & Giddens Suicidality Phenomena Definitions across scales / assessments, use the T-CASA to S&G Phenomena Definitions Mapping Tables Scoring Forms.
Training Slides (coming soon)
License Agreements for Use of the T-CASA
To license any version of the T-CASA for Use in a Study or for a Healthcare System:
• To License the Paper / PDF Version for Use in a Research Study with Grants ≥$50,000 or for a Pharmaceutical Company – There is a charge of $2 per single administration (not per patient enrolled). The amount is payable in full before study initiation. (click here to download this license agreement)
• To License the Paper / PDF Version for Use in a Research Study with Grants <$50,000 – The T-CASA is available free of charge to undergraduate and graduate students and for academic colleagues for educational use and for use in a small study with less than $50,000 funding as long as it is properly cited and proper copyright attribution is given on any study documents. (click here to download this license agreement)
• To License the Paper / PDF Version for Use in a Healthcare System – There is a charge of $2 per single administration (not per patient). The amount is payable in full before use. (click here to download this license agreement)
Training for the T-CASA
Translations and Linguistic Validation of the T-CASA
Mapi (http://www.mapigroup.com) is the official translation and linguistic validation service for all variants of the T-CASA.
MAPI Language Services is the exclusive coordinating center to ensure the production of consistent and conceptually equivalent translations of the T-CASA and to provide linguistic validation and certification of these translations and should be contacted directly for this purpose. MAPI Language Services may charge its own usual fees for this work.
MAPI Research Trust
27 Rue de la Villette
69003 Lyon France
tel: +33 (0)4 72 13 66 67
fax: +33 (0)4 72 13 66 68 / +33 (0)4 72 13 69 50
How to Cite the T-CASA
Use the following citations in referencing the T-CASA:
1. Sheehan DV, Giddens JM. (2015). Suicidality: A Roadmap for Assessment and Treatment. (1st ed.). Tampa, FL: Harm Research Press. Nov. 2015 (Available from: http://HarmResearch.org) ISBN: 978-0-9969729-0-1
2. Sheehan DV, Giddens JM. (2016). Suicidality Assessment and Documentation for Healthcare Providers: A Brief, Practical Guide. (1st ed.). Tampa, FL: Harm Research Press. April 2016. (Available from: http://HarmResearch.org) ISBN: 978-0-9969729-1-8